s6y
Company name or ticker
Search
BIOTECHNOLOGY VALUE FUND II LP
3
ESSA Pharma Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, July 21, 2022
Period
Jul 11, 2022
Accession number
0000921895-22-002269
Documents
OWNERSHIP DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header